Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reynoutrin targets EphB4 to ameliorate hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus. | Biochem Pharmacol | 2025 | 40645601 | PubTator, text mining | PubMed |
| Cracking the Kinase Code: Urinary Biomarkers as Early Alarms for AAA Rupture-A Pilot Study. | J Clin Med | 2025 | 40507607 | PubTator, text mining | PubMed |
| Refractory Diarrhea Related to EPHB4 Mutation in a Patient With Capillary Malformation-Arteriovenous Type 2 Syndrome. | ACG Case Rep J | 2025 | 40469463 | PubTator, text mining | PubMed |
| Identification of EPHB4 as a potential causal gene and therapeutic target for endometriosis using Mendelian randomization. | Hereditas | 2025 | 40450304 | PubTator, text mining | PubMed |
| RNA profiling and immunohistochemistry analyses of circRNAs in imatinib-resistant gastrointestinal stromal tumors. | J Transl Med | 2025 | 40448136 | PubTator, text mining | PubMed |
| [Circ_EPHB4 regulates temozolomide sensitivity in glioma cells through the miR-424-5p/Wnt3 axis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 40415425 | PubTator, text mining | PubMed |
| Arteriovenous cerebral high-flow shunts: genetic analysis of patients from a pediatric tertiary care center. | Front Genet | 2025 | 40259928 | PubTator, text mining | PubMed |
| Discovery of Novel Multiangiogenic Agents Targeting VEGFR2, EphB4, FGFR-1, and TIE-2: Receptor-Based Pharmacophore Modeling, Virtual Screening, and Molecular Modeling Studies. | ACS Omega | 2025 | 40256504 | PubTator, text mining | PubMed |
| Changes in vascular identity during vascular remodeling. | JVS Vasc Sci | 2025 | 40213096 | PubTator, text mining | PubMed |
| Decompensated liver failure due to portal hypertension as a result of hepatic arteriovenous malformations. | BMJ Case Rep | 2025 | 40194806 | PubTator, text mining | PubMed |
| Study of the survival of patients with head and neck cancer in relation to Circulating Tumor Cells (CTCs). | PLoS One | 2025 | 40168331 | PubTator, text mining | PubMed |
| The paradigm shifts of periodontal regeneration strategy: From reparative manipulation to developmental engineering. | Bioact Mater | 2025 | 40165829 | PubTator, text mining | PubMed |
| Alendronate inhibits bone-specific blood vessels in the femoral metaphyses of mice. | J Oral Biosci | 2025 | 40118179 | PubTator, text mining | PubMed |
| Expression Profiles of Five Common Cancer Membrane Protein Antigens Collected for the Development of Cocktail CAR-T Cell Therapies Applicable to Most Solid Cancer Patients. | Int J Mol Sci | 2025 | 40076777 | PubTator, text mining | PubMed |
| A data-driven generative strategy to avoid reward hacking in multi-objective molecular design. | Nat Commun | 2025 | 40069140 | PubTator, text mining | PubMed |
| Unusual Presentation of Coronary Artery Fistula in Capillary Malformation Arteriovenous Malformation 2 Syndrome: A Case Report. | Am J Med Genet A | 2025 | 40047120 | PubTator, text mining | PubMed |
| Feasibility of Intratumoral Administration With EPHB4-CAR-T Cells for the Treatment of Oral Squamous Cell Carcinoma. | Cancer Sci | 2025 | 40029791 | PubTator, text mining | PubMed |
| Whole exome sequencing for identifying rare genetic variants related to idiopathic granulomatous mastitis. | Clin Rheumatol | 2025 | 39992598 | PubTator, text mining | PubMed |
| The physics-AI dialogue in drug design. | RSC Med Chem | 2025 | 39906313 | PubTator, text mining | PubMed |
| Transformer Decoder Learns from a Pretrained Protein Language Model to Generate Ligands with High Affinity. | J Chem Inf Model | 2025 | 39871540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=5